News

NovaBay has granted the underwriters a 30-day option to purchase up to an additional 750,000 shares at the initial public offering (IPO) price to cover over-allotments, if any.

The company named experienced executives Khatuna Janjalia, president and Kartlos Edilashvili, vice president of the Geneva branch office. Ms Janjalia joins Calypte from the Audit Control and Expertise

With offices in Tokyo, Osaka, Fukuoka and Sapporo, Central Scientific Commerce (CSC) is a subsidiary of GSI Creos Corporation. Mr Clint Severson, chairman and CEO of Abaxis, said:

New data also demonstrated excellent in vitro activity of Enzon’s customized linker technology when applied to the locked nucleic acid (LNA) antagonists, the company said. The study showed

Dr Intae Lee with the University of Pennsylvania presented the pre-clinical in vivo data at the American Society for Therapeutic Radiology and Oncology (ASTRO) 49th Annual Meeting in

The European Commission’s decision to approve Nexavar is based on positive data from the international Phase III placebo-controlled sorafenib hepatocellular carcinoma (HCC) assessment randomized protocol (SHARP) trial, which

The treatment will commence after completion of the initial screening. The study encompasses a total of 12 treatment naive patients with chronic hepatitis C virus genotype 1 infections

The TEG product line, which includes equipment, software and consumables, has been marketed successfully for over seven years. The TEG system is a proven technology backed by scores

With almost 25,000 square feet, the new facility offers a five-times increase in testing capacity, four times the space to produce clinical trial kits, and a wider range